The -675 4g/5g polymorphism in plasminogen activator inhibitor-1 gene is associated with risk of asthma: A meta-analysis

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Nie, Wei ^a   Li, Bing ^a   Xiu, Qing yu ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASTHMA; BIBLIOGRAPHIC DATABASE; CONTROLLED STUDY; DISEASE PREDISPOSITION; GENE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MOLECULAR PATHOLOGY; PLASMINOGEN ACTIVATOR INHIBITOR 1 GENE; RISK FACTOR; SYSTEMATIC REVIEW; FACTUAL DATABASE; GENETICS; META ANALYSIS; PROMOTER REGION; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

PLASMINOGEN ACTIVATOR INHIBITOR 1;

ASTHMA; DATABASES, FACTUAL; HUMANS; ODDS RATIO; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC;

EID: 84858995952     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034385     Document Type: Article

References (25)

1. Masoli M, Fabian D, Holt S, Beasley R, (2004) The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 59: 469-478.
2. Mukherjee AB, Zhang Z, (2011) Allergic Asthma: Influence of Genetic and Environmental Factors. J Biol Chem 286: 32883-32889.
3. Kelly MM, Leigh R, Bonniaud P, Ellis R, Wattie J, et al. (2005) Epithelial expression of profibrotic mediators in a model of allergen-induced airway remodeling. Am J Respir Cell Mol Biol 32: 99-107.
4. Kowal K, Bodzenta-Lukaszyk A, Pampuch A, Szmitkowski M, Donati MB, et al. (2007) Plasminogen activator inhibitor-1 plasma concentration in allergic asthma patients during allergen challenge. Int Arch Allergy Imm 144: 240-246.
5. Xu J, Postma DS, Howard TD, Koppelman GH, Zheng SL, et al. (2000) Major genes regulating total serum immunoglobulin E levels in families with asthma. Am J Hum Genet 67: 1163-1173.
6. Eriksson P, Kallin B, Van't Hooft FM, Båvenholm P, Hamsten A, (1995) Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. P Natl Acad Sci USA 92: 1851-1855.
7. Bučková D, Izakovičová Hollá L, Vácha J, (2002) Polymorphism 4G/5G in the plasminogen activator inhibitor-1 (PAI-1) gene is associated with IgE-mediated allergic diseases and asthma in the Czech population. Allergy 57: 446-448.
8. Pampuch A, Kowal K, Bodzenta-Lukaszyk A, Castelnuovo AD, Chyczewski L, et al. (2006) The -675 4G/5G plasminogen activator inhibitor-1 promoter polymorphism in house dust mite-sensitive allergic asthma patients. Allergy 61: 234-238.
9. Hizawa N, Maeda Y, Konno S, Fukui Y, Takahashi D, et al. (2006) Genetic polymorphisms at FCεR1B and PAI-1 and asthma susceptibility. Clin Exp Allergy 2006 36: 872-876.
10. Kowal K, Bodzenta-Lukaszyk A, Pampuch A, Szmitkowski M, Zukowski S, et al. (2008) Analysis of -675 4G/5G SERPINE1 and C-159T CD14 polymorphisms in house dust mite-allergic asthma patients. J Investig Allergol Clin Immunol 18: 284-292.
11. Ozbek OY, Atac FB, Ogus E, Ozbek N, (2009) Plasminogen activator inhibitor-1 gene 4G/5G polymorphism in Turkish children with asthma and allergic rhinitis. Allergy Asthma Proc 30: 41-46.
12. Cosan D, Kurt E, Kurt H, Degirmenci I, Kuçukarabaci B, et al. (2009) Plasminogen Activator Inhibitor Type-1 Gene 4G/5G Polymorphism in Turkish Adult Patients with Asthma. Genet Test Mol Biomarkers 13: 543-546.
13. Zhang X, Ling J, Liu C, Su N, Cheng X, et al. (2009) A study of genetic polymorphism at PAI-1 and asthma susceptibility. Zhonghua Jie He He Hu Xi Za Zhi 32: 210-212.
14. Dijkstra A, Postma DS, Bruinenberg M, van Diemen CC, Boezen H, Koppelman G, et al. (2011) SERPINE1 -675 4G/5G polymorphism is associated with asthma severity and inhaled corticosteroid response. Eur Respir J 38: 1036-1043.
15. Begg CB, Mazumdar M, (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1101.
16. Egger M, Smith GD, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
17. Koppelman GH, (2006) Gene by environment interaction in asthma. Curr Allergy Asthma Rep 6: 103-111.
18. Murphy DM, O'Byrne PM, (2010) Recent advances in the pathophysiology of asthma. Chest 137: 1417-1426.
19. Ma Z, Paek D, Oh C, (2009) Plasminogen activator inhibitor-1 and asthma: role in the pathogenesis and molecular regulation. Clin Exp Allergy 39: 1136-1144.
20. Savov JD, Brass DM, Berman KG, McElvania E, Schwartz DA, (2003) Fibrinolysis in LPS-induced chronic airway disease. Am J Physiol Lung Cell Mol Physiol 285: L940-L948.
21. Sejima T, Madoiwa S, Mimuro J, Sugo T, Okada K, et al. (2005) Protection of plasminogen activator inhibitor-1-deficient mice from nasal allergy. J Immun 174: 8135-8143.
22. Oh CK, Ariue B, Alban RF, Shaw B, Cho SH, (2002) PAI-1 promotes extracellular matrix deposition in the airways of a murine asthma model. Biochem Biophys Res Commun 294: 1155-1160.
23. Festa A, D'Agostino R Jr, Rich SS, Jenny NS, Tracy RP, et al. (2003) Promoter (4G/5G) plasminogen activator inhibitor-1 genotype and plasminogen activator inhibitor-1 levels in blacks, Hispanics, and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study. Circulation 107: 2422-2427.
24. Cho SH, Hall IP, Wheatley A, Dewar J, Abraha D, et al. (2001) Possible role of the 4G/5G polymorphism of the plasminogen activator inhibitor 1 gene in the development of asthma. J Allergy Clin Immun 108: 212-214.
25. Salanti G, Sanderson S, Higgins J, (2005) Obstacles and opportunities in meta-analysis of genetic association studies. Genet Med 7: 13-20.